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• SB administration was able to reverse the impairment in aversive memory induced by CLP.
• SB administration inhibited the HDAC activity in brain regions 10 days after CLP.
• The results may contribute to understanding of cognitive damage in septic rats.
• The ﬁndings support HDACi as a possible adjunctive therapy for sepsis.
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a b s t r a c t
Epigenetic mechanisms are involved in normal behavior and are implicated in several brain neurodegen-
erative conditions, psychiatric and inﬂammatory diseases as well. Moreover, it has been demonstrated
that sepsis lead to an imbalance in acetylation of histones and that histone deacetylase inhibitors (HDACi)
can reverse this condition. In the present study, we evaluated the effects of a microinjection of sodium
butyrate (SB, HDACi) into cerebral ventricle on aversive memory in rats submitted to the sepsis. Rats
were given a single intraventricular injection of artiﬁcial cerebrospinal ﬂuid (ACSF) or SB and immedi-
ately after the stereotaxic surgery and the drug infusion, the animals were subjected to cecal ligation
and perforation (CLP). The animals were killed twenty four hours or ten days after sepsis induction and
the prefrontal cortex, hippocampus, striatum and cortex were obtained to the determination of histone
deacetylase activity. In a separate cohort of animals 10 days after sepsis induction, it was performed the
inhibitory avoidance task. SB administration was able to reverse the impairment in aversive memory
and inhibited the HDAC activity in prefrontal cortex and hippocampus 10 days after CLP. These support
a role for an epigenetic mechanism in the long-term cognitive impairments observed in sepsis survivors
animals.
© 2015 Elsevier Ireland Ltd. All rights reserved.
Abbreviations: ACSF, artiﬁcial cerebrospinal ﬂuid; BDNF, brain-derived neu-
rotrophic factor; CLP, cecal ligation and perforation; DTT, dithiothreitol; HAT,
histone acetyltransferase; HDAC, histone deacetylase; HDACi, histone deacetylase
inhibitors; NGF, nerve growth factor; SAHA, suberoylanilide hydroxamic acid; SB,
sodium butyrate; TSA, trichostatin A; VPA, valproate.
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1. Introduction
Histonemodiﬁcations are an importantmechanismtomodulate
chromatin structure and gene expression [1]. Histone acetylation is
reversibly and controlled by the balance of enzymes called histone
acetyltransferase (HAT), which acetylates histones, and histone
deacetylase (HDAC), which catalyzes the deacetylation of histones
[2]. Histone acetylation at gene promoters is related to increased
http://dx.doi.org/10.1016/j.neulet.2015.04.019
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gene transcription, while deacetylation is connected with inactiva-
tion of gene expression [3].
Histone deacetylase inhibitors (HDACi), such as valproate (VPA),
trichostatin A (TSA), suberoylanilide hydroxamic acid (SAHA),
and sodium butyrate (SB) prevent deacetylation and typically
up-regulate gene expression being implicated in the epigenetic
programming associatedwith regulation of behavior and cognition
[4,5]. Indeed, epigenetic mechanisms are also implicated in sev-
eral brain neurodegenerative conditions, psychiatric disorders and
inﬂammatory diseases [6,7]. Besides, the organization of chromatin
appears to play a central role in the regulation of gene expression
involved in the inﬂammatory process [8].
Sepsis is characterized by deregulated inﬂammation and
immune responses [9]. Despite the relevance of sepsis its patho-
physiology is not fully understood. It is a complex process
that involves the immune system; coagulation, endocrine and
metabolic pathways; and also linked to an imbalance between
ROS formation and clearance [10]. Moreover, it has been demon-
strated that sepsis lead to an imbalance in acetylation of histones
and that HDACi can reverse this, [11] reducing the release of TNF-
, IL-1 and IFN- [12], and exerting anti-inﬂammatory effects.
Indeed, HDACi, such as SB and TSA, have been reported to decrease
LPS-induced inﬂammation in animals [13].
Evidences in the literature have demonstrated that later after
cecal ligationandperforation (CLP) ratspresentedcognitive impair-
ment [14,15]. However, there are no published studies relating
neither HDAC activity alterations early or late in the brain of sepsis
survivor rats nor its implications in late cognitive damage. Thus,
considering the growing body of evidence of the involvement of
histones in the pathophysiology of sepsis, the present study aims
to evaluate the effects of HDACi on late cognitive impairment in
rats submitted to sepsis.
2. Material and Methods
2.1. Animals
Seventy two adult male Wistar rats (60 days old, weighting
250–300g) were obtained from the Universidade do Extremo Sul
Catarinense (UNESC)breeding colony. Theywere caged (41×34 cm
and 16 cm high) in groups of ﬁve with food and water available ad
libitum and were maintained on a 12-h light–dark cycle (lights on
at 7:00 am), at a temperature of 23 ◦C±1 ◦C. These conditions were
maintained constant throughout the experiments. All experimen-
tal procedures were performed in accordance with the approval of
the local Ethics Committee of Animals Use (Protocol 01/2012).
2.2. Surgical procedure
Animals were intraperitoneally anesthetized with ketamine
(80mg/kg) and xylazine (10mg/kg). In a stereotaxic apparatus, the
skin of the rat skull was removed for placement of a guide cannula
(27 gage 9mm) 1mm above lateral ventricle, according to Paxinos
and Watson [16]. In the ventricle, a single cannula was implanted
in the animals at coordinates: posterior 0.9mm, lateral 1.5mm, and
ventral 3.3mm.
2.3. Drug and infusion procedure
The drug used in the study was sodium butyrate (SB, Sigma,
St. Louis, MO, USA). SB (10mM) was dissolved in artiﬁcial cere-
brospinal ﬂuid (ACSF) and injected directly into the ventricle in a
volume of 5L once just before sepsis induction. Controls groups
receivedACSF infused intracerebroventricularly. Thedoseof SBwas
based on previous studies of Wang et al. [17] and Arent et al. [18].
2.4. Sepsis induction
Immediately after the stereotaxic surgery, the animals were
subjected to CLP, as previously described [19]. Brieﬂy, under asep-
tic conditions, a 3-cm midline laparotomy was performed to allow
exposure of the cecumwith the adjoining intestine. The cecumwas
tightly ligated with a 3.0-silk suture at its base, below the ileoce-
cal valve, and perforated once with a 14-gage needle. The cecum
was then gently squeezed to extrude a small amount of feces from
the perforation site, returned to the peritoneal cavity, followed by
the closure of the laparotomy with 4.0-silk sutures. Animals were
resuscitated with normal saline (50mL/kg subcutaneously) imme-
diately and 12h after CLP. All animals were returned to their cages
with free access to food and water. In the sham operated group, the
rats were submitted to all surgical procedures but the cecum was
neither ligated nor perforated. After surgery, both groups received
30mg/kg ceftriaxone and 25mg/kg clindamycin subcutaneously
every 6h for a total of 3 days. Survival rates were 100% in the
sham group and 40% in the sepsis group, which were in accordance
with our previous reports [20,21]. Each experiment was performed
by a same blinded person. In this study, the animals were divided
in three experimental groups (with n=12): (1) Sham+ACSF, (2)
CLP+ACSF, and (3) CLP+SB.
2.5. Inhibitory avoidance
The animals were subjected to inhibitory avoidance procedure
as previously described by Roesler et al. [22]. The apparatus was
an acrylic box (50×25×25 cm) whose ﬂoor consisted of parallel-
caliber stainless-steel bars (1mm diameter) spaced 1 cm apart, and
aplatformthatwas7 cmwideand2.5 cmhigh.Animalswereplaced
on the platform and their latency to step down on the grid with all
fourpawswasmeasuredwithanautomaticdevice. Training session
was performed 10 days after surgery. Immediately after stepping
down on the grid, animals received a foot shock of 0.3mA and 2 s.
In test session carried out 24h after training, no foot shock was
given and the step-down latency (maximum of 180 s) was used as
a measure of retention. This behavioral test was performed by a
same blinded person.
2.6. HDAC activity
Twenty fourhours and tendays after surgeries, theanimalswere
killed by decapitation and the brain transferred within 1min to
ice-cold isolation buffer (0.23M mannitol, 0.07M sucrose, 10mM
Tris–HCl and1mMEDTA, pH7.4). The prefrontal cortex, hippocam-
pus, striatum and cortex (n=7 animals per group) were obtained.
Samples of brain tissue were submitted to a nuclear extrac-
tion protocol, according to Nuclear Extraction kit (Chemicon, USA).
Brieﬂy, the tissues were homogenized in cytoplasmic lysis buffer
containing dithiothreitol (DTT) and protease inhibitors. The sus-
pension was kept in ice for 15min and was later centrifuged
in 250× g for 5min at 4 ◦C. The supernatant was discarded and
the pellet was resuspended in two volumes of cold cytoplasmic
lysis buffer. The suspension was homogenized using a small gauge
needle syringe and centrifuged in 8000× g for 20min at 4 ◦C.
The resulting pellet contained the nuclear portion of the cellular
lysate. The pellet was resuspended in a nuclear extraction buffer
containing DTT and protease inhibitors, and the suspension was
homogenizedwith a small gaugeneedle syringe. The resulting sam-
ple was kept in slow agitation for 30–60min in an orbital shaker
at 4 ◦C. Later, the nuclear suspension was centrifuged in 16,000× g
for 5min at 4 ◦C and the nuclear extract-containing supernatant
was transferred to a new tube and stored at −80 ◦C until further
analysis.
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Fig. 1. The step-down inhibitory avoidance. Animals were submitted to CLP or
sham-operated. They underwent the training test on the step-down inhibitory
avoidance task 10 days after CLP and were tested 24h later. Data are presented as
median and interquartile ranges, n=12 rats per group. *P<0.05 versus sham group.
The nuclear extracts were submitted to a HDAC activity assay
with the use of HDAC Assay kit (Fluorometric Detection), accord-
ing to the manufacturer’s instructions (Upstate, USA). Brieﬂy, 5L
of nuclear extracts were mixed with 5L of HDAC Assay Buffer and
5L of HDAC Assay Substrate in a 384-well plate and incubated at
30 ◦C for 45min. Concomitantly, a standard curve was performed
with serial dilutionsof deacetylated substrate andpositive andneg-
ative controls were added to the plate. After, 10L of activator
solution were added to the wells and the plate was incubated at
room temperature for 15min. The ﬂuorescence reading was per-
formed in a ﬂuorescence plate reader, with 360nm for excitation
and 460nm for emission. The calculation of the HDAC activity was
performed based on the standard curve, and the values are pre-
sented as micromolars per microgram of protein. Protein content
was measured by the method described by Lowry et al. [23] using
bovine serum albumin as a standard.
2.7. Statistical analysis
Statistical analyses were performed using the Statistical Pack-
age for the Social Science (SPSS) software. Data from the
inhibitory avoidance task were reported as median and interquar-
tile ranges and comparisons among groups were performed using
Mann–Whitney U tests. The within individual groups were ana-
lyzed by Wilcoxon tests. All data from biochemical analyses were
ﬁtted ina standarddistribution curveandwere therefore, subjected
to parametric analyses. For the comparisons between the groups,
one-way analysis of variance (ANOVA) test was performed, fol-
lowed by the LSD post-hoc test. Values of P<0.05 were considered
to be statistically signiﬁcant.
3. Results
Fig. 1 demonstrates the test section step-down latency of
the inhibitory avoidance. Ten days after CLP, it was signiﬁcantly
decreased in the sepsis group (Z=1.266, P=0.002) when compared
to the sham group. SB administration was able to reverse the
impairment in aversive memory (Z=2.194, P=0,002) observed in
the sepsis group.
HDAC activity is shown in Fig. 2(A and B). It was observed
an increase in the HDAC activity in hippocampus (f=4.879, df = 2,
P=0.023) and cortex (f=3.087, df = 2, P=0.026) 24h after CLP in
septic animals when compared to sham (Fig. 2A). However, SB
administration in sepsis group did not inhibited the HDAC activ-
ity in both structures (hippocampus and cortex). Additionally, in
other brain structures (prefrontal cortex and striatum) there were
no statistical differences between groups.
At longer times after sepsis induction (10 days, Fig. 2B), it was
demonstrated an increase in the HDAC activity only in prefrontal
cortex (f=7.951, df = 2, P=0.003) and hippocampus (f=6.617, df = 2,
P=0.006) in sepsis group. In the others brain regions (striatum and
cortex), there were no statistical differences between groups. SB
administration in sepsis group inhibited the HDAC activity only in
the prefrontal cortex and hippocampus, but not in striatum and
cortex (10 days).
4. Discussion
Literature data shows that epigenetics mediates diverse envi-
ronmental aspects involved in the pathophysiology of psychiatric
and inﬂammatory diseases [24,25]. In this study, we observed
that SB administration was able to reverse the impaired aversive
memory and inhibited the HDAC activity in prefrontal cortex and
hippocampus after 10 days CLP surgery, suggesting that HDAC
activity could be associated to memory impairment.
Our results are in agreement with published data suggesting
that inﬂammatory and immune responses evoked by sepsis may
induce brain dysfunction andmemory impairment [26,27]. It is also
known that neurotrophins – such as brain-derived neurotrophic
factor (BDNF) and nerve growth factor (NGF) – play an important
role in neuronal differentiation, survival and growth of neurons
and control neuronal cell death during brain development [28]. In
this context, BDNF levels [19] and hippocampal volume [29] are
decreased after sepsis.
Some authors have explored the connection between HDACs
and BDNF in nervous system dysfunction [30,31]. Additionally,
HDACis have been shown to potentiate memory and synaptic plas-
ticity and to ameliorate cognitive deﬁcits and neurodegeneration
[32,33]. In addition, histone acetylation is regulated during mem-
ory formation [34,35]. Accordingly, SB has been shown to increase
BDNF levels in vitro [36]. Wu et al. [2] demonstrated that HDACi
up-regulate astrocyteglial cell line-derivedneurotrophic factor and
BDNF gene transcription, protecting dopaminergic neurons. Subse-
quently, the same authors showed that chronic treatmentwithVPA
reversed cognitive deﬁcits probably by decreasing inﬂammation
and apoptosis in the brain, as well as the activation of the BDNF-
TrkB signaling pathway [37]. This was also demonstrated in animal
models of traumatic brain injury and brain ischemia [38,39].
From a mechanistically point of view, it is not possible to ascer-
tain if these observed effects were related to a decrease in systemic
inﬂammation or were associated with an speciﬁc central effect.
Thus, our results add to previously published since we adminis-
tered HDACi directly into the CSF, avoiding in that way its systemic
effects.
Moreover, pretreatment with HDACi, such as SB, VPA, and TSA
decreased lipopolysaccharide-induced inﬂammatory responses
and protected dopaminergic neurons from damage in cell culture
[40].
Here, HDAC activity was increased in the sepsis group in hip-
pocampus and cortex in 24h after CLP induction; and in prefrontal
cortex and hippocampus 10 days after sepsis. In fact, inﬂamma-
tory diseases such as sepsis can induce increase HDAC activity,
decreasing or inactivating gene transcription [37,41], but this is
the ﬁrst demonstration that HDAC activity is up-regulated in the
brain longer after sepsis. However, SB administration reverses this
only in prefrontal cortex and hippocampus at 10 days. This can be
explained partly because regions of the brain may respond differ-
ently to sepsis, due to the heterogeneous subsets of cell population.
Furthermore, evenwithin a homogeneous population of cells, there
is heterogeneity in terms of metabolic and physiological aspects
[42].
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Fig. 2. Microinjection of SB or ACSF in the ventricle. HDAC activity in the brain (prefrontal cortex, hippocampus, striatum and cortex) of sepsis survivors rats 24h (A) and 10
days (B) after CLP. Bars represent means± SEM of 7 rats. *P<0.05 versus sham group. #P<0.05 versus CLP group.
Additionally, several factors that may inﬂuence HDAC activity
could explain these differences, such as comorbidities and staging
of sepsis. Likewise, in studies with animals, some variables could
have a direct impact on the results [43]. In this study, the absence
of alterations in HDAC activity is likely to be related to the duration
of SB treatment, which was acute.
5. Conclusions
SB administration was able to reverse the impaired aversive
memory and inhibited the HDAC activity in prefrontal cortex and
hippocampus 10 after days CLP. These ﬁndings may contribute to
a better understanding of cognitive damage in sepsis survivor and
support HDACi as a possible adjunctive therapy for sepsis.
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